<p>This calls for an improvement in the existing TB program towards strengthening adherence by patients accessing the facility for TB treatment. Rifampicin resistant TB is a factor to be considered in refractory cases, hence the need for continuous monitoring of drug resistance trends, to assess the efficacy of current interventions and their impact on the TB epidemic.</p>